They found that those who took GLP-1s had a 46% lower risk of death from any cause during the follow-up period of about 5.5 years
Together, these two incretins contribute to metabolic homeostasis, preventing both hyperglycemia and hypoglycemia, mitigating dyslipidemia, and reducing the risk of cardiovascular diseases in individuals with type 2 diabetes and obesity
The practical reality is that most people on GLP-1 medications find their relationship with alcohol changes whether they intend it to or not
Asia Pacific to Register Fastest Growth at 14.1% CAGR Through Forecast Period The Asia Pacific GLP-1 receptor agonist market is projected to witness the fastest growth rate of CAGR 14.1% during the forecast period, driven by a rapidly rising prevalence of diabetes and obesity across major economies such as China, India, and Japan
We investigated the impact of tirzepatide on blood pressure, cardiac function, and sympathetic nervous system activity in stroke-prone spontaneously hypertensive rats
It is normal not to lose much (or any) weight during the first week of semaglutide GLP-1 treatment